1. Matz PG, Meagher RJ, Lamer T, et al. Guideline summary review: an evidence-based clinical guideline for the diagnosis and treatment of degenerative lumbar spondylolisthesis. Spine J. 2016;16(3):439–48.
2. Jacobsen S, Sonne-Holm S, Rovsing H,et al.Degenerative lumbar spondylolisthesis: an epidemiological perspective: the Copenhagen Osteoarthritis Study. Spine (Phila Pa1976). 2007;32(1):120–5.
3. Sclafani JA, Constantin A, Ho PS, et al. Descriptive analysis of spinal neuroaxial injections, surgical interventions, and physical therapy utilization for degenerative lumbar spondylolisthesis within medicare beneficiaries from 2000 to 2011. Spine (Phila Pa 1976). 2017;42(4):240–6.
4. Gerling MC, Leven D, Passias PG,et al. Risks factors for reoperation in patients treated surgically for degenerative spondylolisthesis: a subanalysis of the 8 year data from the SPORT trial. Spine (Phila Pa 1976). 2017,42(20):1559-1569.
5. Forsth P, Olafsson G, Carlsson T, et al. A randomized, controlled trial of fusion surgery for lumbar spinal stenosis. N Engl J Med. 2016;374(15):1413–23.
6. Weinstein JN, Lurie JD, Tosteson TD, et al. Surgical versus nonsurgical treatment for lumbar degenerative spondylolisthesis. N Engl J Med. 2007;356(22): 2257–70.
7. Ghogawala Z, Dziura J, Butler WE, et al. Laminectomy plus fusion versus laminectomy alone for lumbar spondylolisthesis. N Engl J Med. 2016;374(15):1424–34.
8.Challier V, Boissiere L, Obeid I, et al. One-level lumbar degenerative spondylolisthesis and posterior approach: is transforaminal lateral interbody fusion mandatory?A randomized controlled trial with 2-year follow-up. Spine(Phila Pa 1976). 2017;42(8):531–9.
9.Isaacs RE, Sembrano JN, Tohmeh AG, Group SDS. Two-year comparative outcomes of MIS lateral and MIS transforaminal interbody fusion in the treatment of degenerative spondylolisthesis. Part II: radiographic findings. Spine (Phila Pa 1976). 2016;41(Suppl 8):S133–44.
10.Sembrano JN, Tohmeh A, Isaacs R, Group SDS. Two-year comparative outcomes of MIS lateral and MIS transforaminal interbody fusion in the treatment of degenerative spondylolisthesis. Part I: clinical findings. Spine (Phila Pa 1976). 2016;41(Suppl 8):S123–32.
11. Matsunaga S, Ijiri K, Hayashi K. Nonsurgically managed patients with degenerative spondylolisthesis: a 10- to 18-year follow-up study. J Neurosurg. 2000;93(2 Suppl):194–8.
12. Pearson AM, Lurie JD, Blood EA, et al. Spine patient outcomes research trial: radiographic predictors of clinical outcomes after operative or nonoperative treatment of degenerative spondylolisthesis. Spine (Phila Pa 1976).2008;33(25):2759–66.
13.Musluman AM, Cansever T,et al. Midterm outcome after a microsurgical unilateral approach for bilateral decompression of lumbar degenerative spondylolisthesis. J Neurosurg Spine. 2012;16(1):68–76.
14. Aihara T, Toyone T, Aoki Y, et al. Surgical management of degenerative lumbar spondylolisthesis: a comparative study of outcomes following decompression with fusion and microendoscopic decompression.J Musculoskelet Res. 2012;15(4):1250020.
15. Inui T, Murakami M, Nagao N, et al. Lumbar degenerative spondylolisthesis: changes in surgical indications and comparison of instrumented fusion with two surgical decompression procedures. Spine (Phila Pa 1976). 2017;42(1):E15–24.
16. Ahmad S, Hamad A, Bhalla A, et al. The outcome of decompression alone for lumbar spinal stenosis with degenerative spondylolisthesis. Eur Spine J. 2017;26(2):414–9.
17. Mardjetko SM, Connolly PJ, Shott S. Degenerative lumbar spondylolisthesis. A meta-analysis of literature 1970-1993. Spine(Phila Pa 1976). 1994;19(20 Suppl):2256S–65S.
18.Ghogawala Z, Benzel EC, Amin-Hanjani S, et al. Prospective outcomes evaluation after decompression with or without instrumented fusion for lumbar stenosis and degenerative Grade I spondylolisthesis. J Neurosurg Spine 2004;1:267–72.
19.Blumenthal C, Curran J, Benzel EC, et al. Radiographic predictors of delayed instability following decompression without fusion for degenerative grade I lumbar spondylolisthesis. J Neurosurg Spine 2013;18:340–6.
20. Martin CR, Gruszczynski AT, Braunsfurth HA, et al. The surgical management of degenerative lumbar spondylolisthesis: a systematic review. Spine (Phila Pa 1976).2007;32(16):1791–8.
21. Rousseau MA, Lazennec JY, Bass EC, et al. Predictors of outcomes after posterior decompression and fusion in degenerative spondylolisthesis. Eur Spine J. 2005;14(1):55–60.
22.Shunsuke Sato, Mitsuru Yagi, Masayoshi Machida et al.Reoperation rate and risk factors of elective spinal surgery for degenerative spondylolisthesis: minimum 5-year follow-up .The Spine Journal, 2015,15:1536–1544 .
23.Liu J-M, Deng H-L, Peng A-F, et al. Unplanned reoperation of lumbar spinal surgery during the primary admission. Spine (Phila Pa 1976) 2016;41:1279-83 .
24.Núñez-Pereira S1,Pellisé F1,Rodríguez-Pardo D, et al. Implant survival after deep infection of an instrumented spinal fusion. Bone Joint J 2013;95-B:1121–6.
25.Kim CH, Chung CK, Park CS, et al. Reoperation rate after surgery for lumbar spinal stenosis without spondylolisthesis: a nationwide cohort study. Spine J 2013;13:1230–7.
26.Schuster JM, Rechtine G, Norvell DC, et al. The influence of perioperative risk factors and therapeutic interventions on infec- tion rates after spine surgery: a systematic review. Spine (Phila Pa 1976) 2010;35:S125–37.
27.Deyo RA. Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults. JAMA 2010;303:1259–65.
28. Okuda S, Iwasaki M, Miyauchi A, et al. Risk factors for adjacent segment degeneration after PLIF. Spine 2004;29:1535–40.